Last reviewed · How we verify
Aspirin with P2Y12 receptor inhibitor — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Aspirin with P2Y12 receptor inhibitor (Aspirin with P2Y12 receptor inhibitor) — Dong-A University.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Aspirin with P2Y12 receptor inhibitor TARGET | Aspirin with P2Y12 receptor inhibitor | Dong-A University | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Aspirin with P2Y12 receptor inhibitor CI watch — RSS
- Aspirin with P2Y12 receptor inhibitor CI watch — Atom
- Aspirin with P2Y12 receptor inhibitor CI watch — JSON
- Aspirin with P2Y12 receptor inhibitor alone — RSS
Cite this brief
Drug Landscape (2026). Aspirin with P2Y12 receptor inhibitor — Competitive Intelligence Brief. https://druglandscape.com/ci/aspirin-with-p2y12-receptor-inhibitor. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab